Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (6251)	1/16/2005 3:10:57 AM
From: Robohogs	Respond to of 10345

Thanks for the news. If one extrapolates these numbers that could suggest 10K+ already on the drug which would imply $200-250 MM+ annual revenue already. WOW! All it takes is 50K patients to get $1 B. That Serono commentary strikes me as weird. They may be able to move stocks short term, but long term? That science guy was behaving inappropriately IMHO. Jon

To: rkrw who wrote (6251)	1/16/2005 12:45:09 PM
From: quidditch	Respond to of 10345

rkrw, <MS Center at St. Elizabeth’s Medical Center> Of course, being associated with TUSM, stamps this hospital as a premier site for MS treatment. But I am curious, how is Brighton situation vis a vis other premier Boston medical centers; is St. Elizabeth's the premier MS center in the Boston metropolitan area. Just trying to get a sense of the demographics and numbers that the infusions referenced in this note might suggest. quid (Missed 2nd half of Steelers/Jets, arrgggghhhh. Hopefully one of today's games will be as competitive. Figuring on Pats/Colts. Interesting match up with the injuries on both sides. No dog in that fight though--I'd be satisfied to see either team survive.)